Stay updated on Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Sign up to get notified when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.5 to v3.6.6, replacing the previous revision. This reflects a minor platform update rather than changes to study details or data.
    Difference
    0.1%
    Check dated 2026-08-29T19:37:58.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.6.4 to v3.6.5, indicating a background site update; no changes to the study details are shown.
    Difference
    0.1%
    Check dated 2026-08-08T13:27:52.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a small internal update to the site's documentation or implementation.
    Difference
    0.1%
    Check dated 2026-07-25T06:26:49.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    New revision label v3.6.3 appears on the page, indicating a minor update to the page version. The study details and layout appear unchanged.
    Difference
    0.1%
    Check dated 2026-07-03T22:20:21.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The revision label now shows v3.6.2, replacing v3.6.0, indicating a backend/software update rather than a change to study information.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:25.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    New help and guidance sections have been added, including How to Read a Study Record, Common Questions, and How to Join a Study. There is a recruitment status notice stating no participants are being sought, and the Intervention/Treatment header formatting was standardized with a revision update to v3.6.0 (replacing v3.5.5).
    Difference
    0.5%
    Check dated 2026-06-12T15:51:51.000Z thumbnail image

Stay in the know with updates to Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.